Clinical Trial of Ezogabine (Retigabine) in ALS Subjects

Clinical trial NCT02450552 · COMPLETED

Trial details

NCT number: NCT02450552
Sponsor: Brian Wainger
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2015-06-01
Primary completion: 2018-01-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.